NovoCure Sparks Heavy Momentum as Several U.S. Stocks Post Double-Digit Moves
NovoCure (NVCR) topped U.S. trending lists with a 23.4% jump as markets chased headlines and analyst activity. A range of other equities—from Cleveland-Cliffs to CAPR—posted outsized intraday moves. Volume spikes and large analyst target gaps indicate momentum trading and concentrated interest rather than broad index direction.